what dietary recommendations should be provided for a patient with pre dialysis end stage kidney disease

ATI RN

ATI Capstone Medical Surgical Assessment 1 Quizlet

1. What dietary recommendations should be provided for a patient with pre-dialysis end-stage kidney disease?

A. Reduce phosphorus intake to 700 mg/day
B. Increase sodium intake
C. Restrict protein intake to 0.55-0.60 g/kg/day
D. Limit potassium-rich foods

Correct answer: A

Rationale: The correct recommendation for a patient with pre-dialysis end-stage kidney disease is to reduce phosphorus intake to 700 mg/day. Excessive phosphorus can be harmful to individuals with kidney disease as the kidneys may not be able to effectively remove it from the body. Choices B, C, and D are incorrect. Increasing sodium intake is generally not recommended for patients with kidney disease as it can lead to fluid retention and high blood pressure. Restricting protein intake is important in later stages of kidney disease, but for pre-dialysis end-stage kidney disease, protein intake should be individualized based on the patient's condition. Limiting potassium-rich foods is more relevant for patients with advanced kidney disease or those on dialysis, as impaired kidney function can lead to high potassium levels in the blood.

2. What should the nurse monitor for in a patient with hypokalemia?

A. Monitor for muscle weakness
B. Check deep tendon reflexes (DTRs)
C. Monitor for seizures
D. Monitor for bradycardia

Correct answer: A

Rationale: The correct answer is to monitor for muscle weakness in a patient with hypokalemia. Hypokalemia, which is low potassium levels, can lead to muscle weakness due to its effects on neuromuscular function. Checking deep tendon reflexes (Choice B) is not typically associated with hypokalemia. Seizures (Choice C) are more commonly associated with low calcium levels rather than low potassium levels. Bradycardia (Choice D) is a symptom of hyperkalemia (high potassium levels) rather than hypokalemia.

3. What symptoms are expected in a patient with compartment syndrome?

A. Unrelieved pain, pallor, and pulselessness
B. Localized swelling and numbness
C. Fever and infection
D. Weakness and fatigue

Correct answer: A

Rationale: In a patient with compartment syndrome, the key symptoms include unrelieved pain, pallor, and pulselessness. These symptoms indicate reduced circulation in the affected compartment. Choice B is incorrect as localized swelling and numbness are not typically associated with compartment syndrome. Choice C is incorrect as fever and infection are not primary symptoms of compartment syndrome. Choice D is incorrect as weakness and fatigue are not typically seen in compartment syndrome.

4. What is the preferred electrical intervention for a patient with ventricular tachycardia with a pulse?

A. Defibrillation
B. Synchronized cardioversion
C. Pacing
D. Medication administration

Correct answer: B

Rationale: Synchronized cardioversion is the preferred electrical intervention for ventricular tachycardia with a pulse. In this scenario, the heart still has an organized rhythm, so synchronized cardioversion is used to deliver a shock at a specific point in the cardiac cycle, aiming to restore a normal rhythm. Defibrillation (Choice A) is used for pulseless ventricular tachycardia or ventricular fibrillation. Pacing (Choice C) may be used for bradycardias or certain types of heart blocks. Medication administration (Choice D) can be considered for stable ventricular tachycardia, but synchronized cardioversion is the primary intervention for ventricular tachycardia with a pulse.

5. What is the first medication to administer to a patient experiencing wheezing due to an allergic reaction?

A. Albuterol via nebulizer
B. Methylprednisolone 100 mg IV
C. Cromolyn 20 mg via nebulizer
D. Aminophylline 500 mg IV

Correct answer: A

Rationale: The correct answer is A, Albuterol via nebulizer. Albuterol is the first-choice medication for wheezing due to its fast-acting bronchodilatory effect, which helps in relieving the symptoms quickly. Choice B, Methylprednisolone 100 mg IV, is a corticosteroid used for its anti-inflammatory effects and would be beneficial in reducing inflammation in allergic reactions but is not the first-line treatment for wheezing. Choice C, Cromolyn 20 mg via nebulizer, is a mast cell stabilizer used to prevent asthma attacks but is not the immediate treatment for wheezing during an allergic reaction. Choice D, Aminophylline 500 mg IV, is a bronchodilator but is not typically the initial medication of choice for wheezing in an allergic reaction.